Endoscopic FHL Transfer for Acute Achilles Tendon Rupture (NCT06641401) | Clinical Trial Compass
By InvitationNot Applicable
Endoscopic FHL Transfer for Acute Achilles Tendon Rupture
Greece28 participantsStarted 2023-03-05
Plain-language summary
This observational study aims to evaluate the outcome of endoscopic flexor hallucis longus transfer (FHLt) in patients with acute Achilles tendon rupture (AATR).
Who can participate
Age range18 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Signed Consent Form
* Acute Achilles Tendon Rupture (\<4 weeks)
* Underwent operative treatment with Endoscopic Flexor Hallucis Longus transfer
* More than 24 months postoperative follow-up
* Patients operated after 2015
Exclusion Criteria:
* Inability or Unwillingness to cooperate
* Medically unfit for examination
* Age less than 18 or more than 75 years
* Non-operative Management or any other Surgical Management
* Neglected Achilles Tendon Rupture (\>4 weeks)
* Bilateral Achilles Tendon Rupture
* Patients operated before 1.1.2015 or after 1.1.2023
* Comorbidities interfering with the secondary outcomes (e.g. Venous insufficiency resulting in lower limb excessive edema interferes with ankle and calf circumference, rheumatoid arthritis and/or previous foot and ankle surgery interferes with active and passive range of motion of the ankle, etc)